Tag Archives: PRotonix

May 2012 Safety Labeling Changes

Share

translation servicesTranslate | French translation Spanish translation translate German translate Chinese The MedWatch May 2012 Safety Labeling Changes posting includes 41 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS and PATIENT PACKAGE … Continue reading

Share
Posted in FDA 2012, FDA Label Change | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Proton Pump Inhibitors PPIs Drug Safety Communication

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseProton Pump Inhibitors (PPIs) – Drug Safety Communication: Clostridum Difficile-Associated Diarrhea (CDAD) Can be Associated With Stomach Acid Drugs AcipHex (rabeprazole sodium) Dexilant (dexlansoprazole) Nexium (esomeprazole magnesium)  Omeprazole (omeprazole) Over-the-Counter … Continue reading

Share
Posted in Consumer Products, Family Practice, FDA 2012, FDA Notice, FDA Safety Communication, FDA Warning, Gastroenterology | Tagged , , , , , , , , , , , , , , , , , | Comments Off

MedWatch May 2011 Safety Labeling Changes

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseThe MedWatch May 2011 Safety Labeling Changes posting includes 47 products with safety labeling changes to the following sections: BOXED WARNINGS, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, ADVERSE REACTIONS, PATIENT PACKAGE INSERT, and … Continue reading

Share
Posted in FDA 2011, FDA Label Change | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Comments Off

Proton Pump Inhibitor drugs (PPIs): Drug Safety Communication – Low Magnesium Levels Can Be Associated With Long-Term Use

Share

translation servicesTranslate | French translation Spanish translation translate German translate ChineseProton Pump Inhibitor drugs (PPIs): Drug Safety Communication – Low Magnesium Levels Can Be Associated With Long-Term Use Prescription PPIs include Nexium (esomeprazole magnesium), Dexilant (dexlansoprazole), Prilosec (omeprazole), Zegerid (omeprazole … Continue reading

Share
Posted in Consumer Products, FDA Notice, FDA Warning | Tagged , , , , , , , , , , , , , , | Comments Off